Centrally mediated protective effects of dopamine agonists on digitalis-induced ventricular arrhythmias.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002415:Cats; D003655:Decerebrate State; D003892:Deslanoside / Q000037:antagonists & inhibitors*; D006220:Haloperidol / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007799:Lanatosides / Q000037:antagonists & inhibitors*; D010891:Piribedil / Q000494:pharmacology; D011413:Propantheline / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects
D007799:Lanatosides; D011954:Receptors, Dopamine; D011413:Propantheline; D010891:Piribedil; D006220:Haloperidol; D001058:Apomorphine; D003892:Deslanoside